Tyra Biosciences, Inc. TYRA Investing Cash Flow
Investing Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Tyra Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInInvestingActivities.
The official record: Tyra Biosciences, Inc.’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Tyra Biosciences, Inc.'s investing cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Tyra Biosciences, Inc.'s investing cash flow?
- Tyra Biosciences, Inc. (TYRA) reported investing cash flow of -$120.24M in Q1 2026.
- How has Tyra Biosciences, Inc.'s investing cash flow changed year-over-year?
- Tyra Biosciences, Inc.'s investing cash flow decreased by 475.5% year-over-year, from $32.03M to -$120.24M.
- What is the long-term trend for Tyra Biosciences, Inc.'s investing cash flow?
- Over 2 years (2021 to 2023), Tyra Biosciences, Inc.'s investing cash flow has grown at a 1397.3% compound annual growth rate (CAGR), from -$645K to -$144.61M.
- What does investing cash flow mean?
- Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.